Understanding and Implementing a Quality by Design Program

    /Steven  /Laurenzspeaker of Training Doyensinvite
    Speaker: Steven Laurenz


    More Trainings by this Expert
    Duration: 60 Minutes
    Product Code: 50730
    Level: Intermediate

OVERVIEW

The benefits of applying the quality by design in pharmaceutical development have been well advertised. Most important are the direct benefits to our primary customer; the patient.

Per Janet Woodcock M.D. Director, Center for Drug Evaluation and Research (CDER), Food and Drug Administration

“All products are designed and developed to be of high quality"

QbD provides a structured framework for developing, documenting and presenting development rationale, experience and knowledge of the formulation and the process, and to ensure manufacture of products consistently fit for patient use.” Application of these principles can also benefit the pharmaceutical companies by improving manufacturing efficiency and promoting innovation.

WHY SHOULD YOU ATTEND

However, implementing these principles into the pharmaceutical development culture can be challenging.

QbDin pharmaceuticals involves a complex set of interactions, technologies and systems that are not easy to grasp. This training will explain the main principles behind a QbD approach and provide guidelines in how to implement the concepts into a pharmaceutical development organization.

Topics covered will include the target product quality profile, risk assessment, methods to establish a design space, and design of a control strategy. This review will help bridge the gap between understanding the principles and practical application.

AREAS COVERED

  • Quality Target Product Profile (QTPP)
  • Risk Assessment
  • Using Models
  • Design of Experiments
  • Developing a Design Space
  • Process Analytical Technology (PAT)
  • FMEA and Control Plan
  • Target Operational Profile
  • Control Strategy

LEARNING OBJECTIVES

This training will explain the main principles behind a QbD approach and provide guidelines in how to implement the concepts into a pharmaceutical development organization.

WHO WILL BENEFIT

This course is designed for people tasked with developing, filing, and manufacturing pharmaceutical products especially small molecule oral dosage forms.This includes individuals that have responsibilities for formulation development, scale-up, filing, and commercial manufacture of dosage forms as well as maintaining the high quality of those products.

Following personnel will benefit from the course:

  • Senior quality managers
  • Quality professionals
  • Regulatory professionals
  • Compliance professionals
  • Production supervisors
  • Manufacturing engineers
  • Production engineers
  • Process owners
  • Quality engineers
  • Quality auditors
  • Development professionals
  • Senior development managers

SPEAKER

Years of Experience: 15+ years

Areas of Expertise: Quality by Design, Risk Management, and Quality Assurance

Steven Laurenz, Principal Consultant – BioPhia Consulting Inc., has over 25 years of technical leadership experience in product development, process development, technology transfer, and process optimization. He is skilled in taking new products from early laboratory stage to successful manufacturing launch.

He is an expert in integrating Quality by Design and risk management into product development. He has proven experience in establishing a Quality System for a R&D Quality Assurance organization.

Steven has headed product development departments at Abbott Laboratories and AbbVie Inc. and held leadership positions in numerous technical consortium.Steven Laurenz holds an M.S. in Chemical Engineering from the Michigan State University

View all trainings by this speaker

Purchase Options

Apologies. This webinar is currently unavailable. Please contact our Customer Support team on +1-720-996-1616 to know more.

refer friend

Approved Enablers of your
Continuing Education Credits

shrmhrci
View all CEU Approved Webinars